Globus Medical Reports First Quarter 2024 Results
Globus Medical, Inc. Class A (GMED)
Last globus medical, inc. class a earnings: 2/20 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.globusmedical.com
Company Research
Source: GlobeNewswire
AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024. Worldwide net sales were $606.7 million, an increase of 119.3%, or 119.8% on a constant currency basisGAAP net loss for the quarter was $7.1 millionGAAP diluted earnings per share (“EPS”) was ($0.05) and non-GAAP diluted EPS was $0.72Non-GAAP adjusted EBITDA was $166.6 million, or 27.5% of net sales “Since the NuVasive merger closed in September of last year, we worked aggressively to execute our integration strategy and are making significant progress towards rapidly reaching steady state. I am pleased with the first quarter results delivered by strong teamwork and partnership throughout our organization. Surgeons and hospitals are responding favorably to our best-in-class product offering of clinically advanced devices and enabling technologies and worldwide sales reflect the lon
Show less
Read more
Impact Snapshot
Event Time:
GMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMED alerts
High impacting Globus Medical, Inc. Class A news events
Weekly update
A roundup of the hottest topics
GMED
News
- Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- GMED or PEN: Which Is the Better Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $83.00 to $85.00. They now have an "overweight" rating on the stock.MarketBeat
- Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue? [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Piper Sandler from $55.00 to $60.00. They now have a "neutral" rating on the stock.MarketBeat
GMED
Earnings
- 5/7/24 - Beat
GMED
Sec Filings
- 5/14/24 - Form 4
- 5/10/24 - Form 4
- 5/10/24 - Form 144
- GMED's page on the SEC website